Sino Medical Sciences Technology Inc. (SHA:688108)

China · Delayed Price · Currency is CNY

16.85

+0.55 (3.37%)

Aug 4, 2026, 3:00 PM CST

SHA:688108 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	564.29	525.41	458.74	343.26	192.85	194.36
Revenue Growth	20.44%	14.53%	33.64%	77.99%	-0.77%	-40.64%
Gross Profit	381.9	344.51	266.1	197.62	107.21	134.11
Operating Income	86.4	55.13	-34.98	-74.99	-222.45	-166.1
Net Income	68.78	47.29	1.5	-39.63	-162.38	-130.77
Earnings Per Share	0.15	0.11	0.00	-0.10	-0.40	-0.32
EPS Growth	742.48%	2650.00%	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	495.92
Overseas	29.33
Total	525.25

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	375.98	396.41	291.67	188.64	203.42	287.76
Total Debt	140.2	211.73	225.11	199.49	58.31	44.27
Net Cash (Debt)	235.78	184.68	66.56	-10.85	145.11	243.48
Net Cash Growth	677.38%	177.44%	-	-	-40.40%	-55.31%
Net Cash Per Share	0.52	0.43	0.18	-0.03	0.36	0.60

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	183.54	161.87	131.24	56.84	-111.31	-60.13
Capital Expenditures	-40.07	-45.8	-70.02	-67.67	-110.76	-158.45
Free Cash Flow	143.47	116.07	61.22	-10.83	-222.07	-218.58
Free Cash Flow Growth	115.99%	89.59%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	67.68%	65.57%	58.01%	57.57%	55.59%	69.00%
Operating Margin	15.31%	10.49%	-7.63%	-21.84%	-115.35%	-85.46%
Pretax Margin	16.74%	13.03%	-3.74%	-19.77%	-114.77%	-83.92%
Profit Margin	12.19%	9.00%	0.33%	-11.54%	-84.20%	-67.28%
FCF Margin	25.42%	22.09%	13.35%	-3.16%	-115.15%	-112.46%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	108.44	169.28	2694.18	-	-	-
Forward PE	90.56	178.98	81.33	70.82	70.82	64.39
P/FCF Ratio	47.49	68.96	65.91	-	-	-
PS Ratio	12.07	15.24	8.80	14.99	12.14	17.32